Search | MTSocial

Shubhangi Fusam added blog Health
2025-11-18 12:01:45 -

Cancer Research Breakthrough: Evaluating the Critical Role of Spheroids and Organoids in Personalized Oncology and Therapy Development.
For 3D cell culture models to transition from specialized research tools to mainstream industry standards in pharmaceutical R&D, they must be scalable for High-Throughput Screening (HTS). The inherent complexity and manual handling requirements of 3D cultures—such as precise media changes, matrix embedding, and complex imaging—initially made them difficult to integrate into the...

0 Comments 0 Shares 518 Views 0 Reviews

Please log in to like, share and comment!
Shiv Mehara added blog Health
2025-11-20 10:16:27 -

Alpha Emitter Market: Tripling to $3.09 Billion by 2032
ntrospective Market Research (IMR) has published its latest forecast for the Global Alpha Emitter Market, projecting substantial growth through the end of the decade. According to the report, the market was valued at USD 1.30 billion in 2023 and is expected to grow to USD 3.09 billion by 2032, representing a compound annual growth rate (CAGR) of 10.10% during the 2024–2032 period. This...

0 Comments 0 Shares 935 Views 0 Reviews

Please log in to like, share and comment!
Komal Galande added blog Dance
2025-12-30 09:03:09 -

Colorectal Cancer Treatment Market Advances with Targeted Therapies
"Executive Summary Colorectal Cancer Treatment Market Size and Share: Global Industry Snapshot Data Bridge Market Research analyses a growth rate in the colorectal cancer treatment market in the forecast period 2023-2030. The expected CAGR of colorectal cancer treatment market is tend to be around 4% in the mentioned forecast period. Research and analysis about the key...

0 Comments 0 Shares 31 Views 0 Reviews

Please log in to like, share and comment!
Komal Galande added blog Causes
2025-12-29 07:04:55 -

Is RNA Therapeutics Revolutionizing the Next Generation of Disease Treatment?
"Global Executive Summary RNA Therapeutics Market: Size, Share, and Forecast During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 13.20%, primarily driven by the advancements in mRNA technology, increasing prevalence of chronic diseases, and rising investments in personalized medicine While preparing the first class RNA...

0 Comments 0 Shares 83 Views 0 Reviews

Please log in to like, share and comment!